Search

everythinglearnresearchcommunity

for

Search:↓

The AC 2 peptide from Trapa japonica fruit helps protect hair cells and may treat hair loss.

Finasteride safely lowers DHT levels without affecting hormone levels, helping with conditions like enlarged prostate, acne, and hair loss.

Testosterone conversion to 5α-DHT may not be essential for its effects on the skin.

High levels of testosterone and 5α-DHT can lead to cell death in cells important for hair growth.

DHT affects hair follicle cells by changing microRNA levels, leading to less cell growth and more cell death.

Minoxidil and finasteride can slow hair loss and stimulate regrowth, but won't restore all lost hair or reverse complete baldness.

Impaired androgen production in 46,XY DSDs causes ambiguous genitalia and requires long-term care.

The more lipophilic the progesterone derivative, the better it binds to androgen receptors and has antiandrogenic effects.

Gene mutations can cause problems in male genital development.

Blocking the androgen receptor in skin cells reduces their growth response to male hormones, suggesting a possible treatment for skin conditions linked to androgens.

Male hormones worsen kidney transplant damage, but blocking them helps.

Protein tyrosine kinases are key in male pattern baldness, affecting skin structure, hair growth, and immune responses.

Two drugs, finasteride and minoxidil, are approved for hair loss treatment, but new therapies are being developed.

The document concludes that various skin conditions have specific characteristics and treatments, and highlights the importance of vitamin D in managing these dermatological issues.

Hormonal therapy is a treatment option for acne, the only medical treatment for hirsutism, and the most promising for androgenetic alopecia.

Dutasteride and finasteride affect different cell types differently.

Researchers made two new compounds that could be used for medicine.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

Many treatments for hair loss lack proper testing and FDA approval, so their effectiveness is uncertain.

Aldactone was more effective in reducing hair growth in women with hirsutism than Diane, despite having less impact on hormone levels.

Male and female bodies respond differently to stress, influenced by hormones and development stages, with implications for stress-related diseases.

Certain 4-azasteroids are effective at blocking the enzyme that processes testosterone in human skin and could help treat acne, excessive hair growth, and male pattern baldness.

Removing myelin protein zero-like 3 in mice leads to better metabolism and resistance to obesity.

Androgens block hair growth by disrupting cell signals; targeting GSK-3 may help treat hair loss.

Spironolactone helps regrow hair in women with hair loss.

Androgenetic alopecia linked to COVID-19 severity; drugs reducing androgen receptor activation may help.

Androgens may block hair growth signals, targeting this could treat hair loss.

A patient with a larger than usual genetic mutation had a broader range of symptoms for a muscle disease.

Some hormone-related drugs may protect brain cells in Parkinson's disease differently in men and women.

Optimized film improves finasteride skin absorption and treatment efficiency.